PM&R
Volume 2, Issue 3 , Pages S3-S11 , March 2010

Pediatric Rehabilitation: 1. Common Medical Conditions in Children With Disabilities

  • Chong Tae Kim, MD, PhD

      Affiliations

    • Department of PM&R, University of Pennsylvania, School of Medicine, 3405 Civic Center Boulevard, Philadelphia, PA 19096; The Children's Hospital of Philadelphia, Philadelphia, PA1
    • Corresponding Author InformationAddress correspondence to: C.T.K.
    • ,
  • Elizabeth Moberg-Wolff, MD

      Affiliations

    • Department of PM&R, Medical College of Wisconsin, Milwaukee, WI2
    • ,
  • Melissa Trovato, MD

      Affiliations

    • Department of PM&R, Johns Hopkins University, School of Medicine, Baltimore, MD3
    • ,
  • Heakyung Kim, MD

      Affiliations

    • Department of PM&R and Pediatrics, University of Pennsylvania, School of Medicine4
    • ,
  • Nancy Murphy, MD

      Affiliations

    • Division of General Pediatrics, University of Utah, Salt Lake City, UT5

References 

  1. Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based study of seizures after traumatic brain injuries. N Engl J Med. 1998;338:20–24

    ⁎

  2. Formisano R, Barba C, Buzzi MG, et al. The impact of prophylactic treatment on post-traumatic epilepsy after severe traumatic brain injury. Brain Inj. 2007;21:499–504
  3. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. XIII. Antiseizure prophylaxis. J Neurotrauma. 2007;24:S83–S86

    ⁎

  4. Chang BS, Lowenstein DH. Quality Standards Subcommittee of the American Academy of Neurology (Practice parameter: Antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of American academy of Neurology). Neurology. 2003;60:10–16

    ⁎

  5. Appleton RE, Demellweek C. Post-traumatic epilepsy in children requiring inpatient rehabilitation following head injury. J Neurol Neurosurg Psychiatry. 2002;72:669–672
  6. Medical Research Council Antiepileptic Drug Withdrawal Study Group. Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet. 1991;337:1175–1180
  7. Shinnar S, Vining EP, Mellits ED, et al. Discontinuing antiepileptic medication in children with epilepsy after two years without seizure (A prospective study). N Engl J Med. 1985;313:976–980
  8. Chadwick D, Taylor J, Johnson T. Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it (The MRC Antiepileptic Drug Withdrawal Group). Epilepsia. 1996;37:1043–1050
  9. Berg AT, Shinnar S. Relapse following discontinuation of antiepileptic drugs: A meta-analysis. Neurology. 1994;44:601–608

    ⁎

  10. Peters AC, Brouwer OF, Geerts AT, Arts WF, Stroink H, van Donselaar CA. Randomized prospective study of early discontinuation of antiepileptic drugs in children with epilepsy. Neurology. 1998;50:724–730
  11. Andersson T, Braathen G, Persson A, Theorell K. A comparison between one and three years of treatment in uncomplicated childhood epilepsy: A prospective study. II. The EEG as predictor of outcome after withdrawal of treatment. Epilepsia. 1997;38:225–232
  12. Delgado-Escueta AV, Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology. 1984;34:285–294
  13. Fernandez-Ortega JF, Prieto-Palomino MA, Munoz-Lopez A, Lebron-Gallardo M, Cabrera-Ortiz H, Quesada-Garcia G. Prognostic influence and computed tomography findings in dysautonomic crises after traumatic brain injury. J Trauma. 2006;61:1129–1133
  14. Baguley IJ, Slewa-Younan S, Heriseanu RE, Nott MT, Mudaliar Y, Nayyar V. The incidence of dysautonomia and its relationship with autonomic arousal following traumatic brain injury. Brain Inj. 2007;21:1175–1181

    ⁎

  15. Baguley IJ. The excitatory:inhibitory ratio model (EIR model): At integrative explanation of acute autonomic overactivity syndromes. Med Hypotheses. 2008;70:26–35

    ⁎

  16. Meythaler JM, Stinson AM. Fever of central origin in traumatic brain injury controlled with propranolol. Arch Phys Med Rehabil. 1994;75:816–818
  17. Pranzatelli MR, Pavlakis SG, Gould RJ, De Vivo DC. Hypothalamic-midbrain dysregulation syndrome: Hypertension, hyperthermia, hyperventilation, and decerebration. J Child Neurol. 1991;6:115–122

    ⁎

  18. Blackman JA, Patrick PD, Buck ML, Rust RS. Paroxysmal autonomic instability with dystonia after brain injury. Arch Neurol. 2004;61:321–328
  19. Cuny E, Richer E, Castel JP. Dysautonomia syndrome in the acute recovery phase after traumatic brain injury: Relief with intrathecal Baclofen therapy. Brain Inj. 2001;15:917–925
  20. Baguley IJ, Heriseanu RE, Gurka JA, Nordenbo A, Cameron ID. Gabapentin in the management of dysautonomia following severe traumatic brain injury: A case series. J Neurol Neurosurg Psychiatry. 2007;78:539–541
  21. Carlile MC, Yablon SA, Mysiw WJ, Frol AB, Lo D, Diaz-Arrastia R. Deep venous thrombosis management following traumatic brain injury: A practice survey of the traumatic brain injury model systems. J Head Trauma Rehabil. 2006;21:483–490

    ⁎

  22. Cyr C, Michon B, Pettersen G, David M, Brossard J. Venous thromboembolism after severe injury in children. Acta Haematol. 2006;115:198–200
  23. Azu MC, McCormack JE, Scriven RJ, Brebbia JS, Shapiro MJ, Lee TK. Venous thromboembolic events in pediatric trauma patients: Is prophylaxis necessary?. J Trauma-Inj Infect Crit Care. 2005;59:1345–1349
  24. Simosa HF, Petersen DJ, Agarwal SK, Burke PA, Hirsch EF. Increased risk of deep venous thrombosis with endovascular cooling in patients with traumatic head injury. Am Surgeon. 2007;73:461–464
  25. Radecki RT, Gaebler-Spira D. Deep vein thrombosis in the disabled pediatric population. Arch Phys Med Rehabil. 1994;75:248–250
  26. Sandoval JA, Sheehan MP, Stonerock CE, Shafique S, Rescorla FJ, Dalsing MC. Incidence, risk factors, and treatment patterns for deep vein thrombosis in hospitalized children: An increasing population at risk. J Vasc Surg. 2008;47:837–843

    ⁎

  27. Truitt AK, Sorrells DL, Halvorson E, Starring J, Kurkchubasche AG, Tracy TF, et al. Pulmonary embolism: Which pediatric trauma patients are at risk?. J Pediatr Surg. 2005;40:124–127
  28. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury (V. Deep vein thrombosis prophylaxis). J Neurotrauma. 2007;24:S32–S36

    ⁎

  29. Danish SF, Burnett MG, Ong JG, Sonnad SS, Maloney-Wilensky E, Stein SC. Prophylaxis for deep vein thrombosis in craniotomy patients: A decision analysis. Neurosurg. 2005;56:1286–1292
  30. Junger M, Diehm C, Storiko H, et al. Mobilization versus immobilization in the treatment of acute proximal deep venous thrombosis: A prospective, randomized, open, multicentre trial. Curr Med Res Opinion. 2006;22:593–602

    ⁎

  31. Aschwanden M, Labs KH, Engel H, et al. Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism. Thromb Haemost. 2001;85:42–46
  32. Citta-Pietrolungo TJ, Alexander MA, Cook SP, Padman R. Complications of tracheostomy and decannulation in pediatric and young patients with traumatic brain injury. Arch Phys Med Rehabil. 1993;74:905–909

    ⁎

  33. Cockrell J. Pediatric brain injury rehabilitation. In:  Horn LJ,  Zasler ND editor. Medical Rehabilitation of Traumatic Brain Injury. Philadelphia: Hanley & Belfus; 1996;p. 181–182

    ⁎

  34. Stelfox HT, Crimi C, Berra L, et al. Determinants of tracheostomy decannulation: An international survey. Crit Care. 2008;12:R26
  35. Rapp RP, Young B, Ott L, et al. The favorable effect of early parenteral feeding on survival in head-injured patients. J Neurosurg. 1983;58:906–912
  36. Pepe JL, Barba CA. The metabolic response to acute traumatic brain injury and implications for nutritional support. J Head Trauma Rehabil. 1999;14:462–474
  37. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. XII. Nutrition. J Neurotrauma. 2007;24:S77–S82

    ⁎

  38. Young B, Ott L, Twyman D, et al. The effect of nutritional support on outcome from severe head injury. J Neurosurg. 1987;67:668–676
  39. Myers MA. Gastrointestinal complications of traumatic brain injury. In:  Horn LJ,  Zasler ND editor. Medical rehabilitation of traumatic brain injury. Philadelphia: Hanley & Belfus; 1996;p. 515–524

    ⁎

  40. Kudsk KA, Teasley-Strausburg KM. Enteral Nutrition. In:  Corson JD,  Williamson RCN editor. Surgery. New York: Mosby; 2001;p. 12–181, 8
  41. Michaud L, Guimber D, Blain-Stregloff AS, Ganga-Zandzou S, Gottrand F, Turck D. Longevity of balloon-stabilized skin-level gastrostomy device. J Pediatr Gastroentrol Nutr. 2004;38:426–429
  42. Pedoto MJ, O'Dell MW, Thrun M, Hollifield D. Superior mesenteric artery syndrome in traumatic brain injury: Two cases. Arch Phys Med Rehabil. 1995;76:871–875
  43. Hurvitz EA, Mandac BR, Davidoff G, Johnson JH, Nelson VS. Risk factors for heterotopic ossification in children and adolescents with severe traumatic brain injury. Arch Phys Med Rehabil. 1992;73:459–462

    ⁎

  44. Ragone DJ, Kellerman WC, Bonner FJ. Heterotopic ossification masquerading as deep venous thrombosis in head-injured adult: complications of anticoagulation. Arch Phys Med Rehabil. 1986;67:339–341

    ⁎

  45. Haselkorn JK, Britell CW, Cardenas DD. Diagnostic imaging of heterotopic ossification with coexistent deep-venous thrombosis in flaccid paraplegia. Arch Phys Med Rehabil. 1991;72:227–229
  46. Sobus KM, Sherman N, Alexander MA. Coexistence of deep venous thrombosis and heterotopic ossification in the pediatric patient. Arch Phys Med Rehabil. 1993;74:547–551

    ⁎

  47. Hendricks HT, Geurts AC, van Ginneken BC, Heeren AJ, Vos PE. Brain injury severity and autonomic dysregulation accurately predict heterotopic ossification in patients with traumatic brain injury. Clin Rehabil. 2007;21:545–553
  48. Subbarao JV, Garrison SJ. Heterotopic ossification: Diagnosis and management, current concepts and controversies. J Spinal Cord Med. 1999;22:273–283
  49. Rivkees SA. Differentiating appropriate antidiuretic hormone secretion, inappropriate antidiuretic hormone secretion and cerebral salt wasting: The common, uncommon, and misnamed. Curr Opinion Pediatr. 2008;20:448–452
  50. Acerini CL, Tasker RC. Endocrine sequelae of traumatic brain injury in childhood. Hormone Res. 2007;68(Suppl 5):14–17
  51. Einaudi S, Bondone C. The effects of head trauma on hypothalamic-pituitary function in children and adolescents. Curr Opinion Pediatr. 2007;19:465–470

    ⁎

  52. Williams SE. Amantadine treatment following traumatic brain injury in children. Brain Inj. 2007;21:885–889

    ⁎

  53. Williams SE, Ris MD, Ayyangar R, Schefft BK, Berch D. Recovery in pediatric brain injury: Is psychostimulant medication beneficial?. J Head Trauma Rehabil. 1998;13:73–81

    ⁎

  54. Hornyak JE, Nelson VS, Hurvitz EA. The use of methylphenidate in paediatric traumatic brain injury. Pediatr Rehabil. 1997;1:15–17
  55. Jha A, Weintraub A, Allshouse A, et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. J Head Trauma Rehabil. 2008;23:52–63
  56. Lombard LA, Zafonte RD. Agitation after traumatic brain injury. Am J Phys Med Rehabil. 2005;84:797–812

    ⁎

  57. Flanagan SR, Greenwald B, Wieber S. Pharmacological treatment of insomnia for individuals with brain injury. J Head Trauma Rehabil. 2007;22:67–70
  58. Shames JL, Ring H. Transient reversal of anoxic brain injury-related minimally conscious state after zolpidem administration: A case report. Arch Phys Med Rehabil. 2008;89:386–388
  59. Singh R, McDonald C, Dawson K, et al. Zolpidem in a minimally conscious state. Brain Inj. 2008;22:103–106
  60. Sachdev P, Kruk J. Restlessness: The anatomy of a neuropsychiatric symptom. Aust N Z Psychiatry. 1996;30:38–50
  61. Lindenmayer J-P. The pathophysiology of agitation. J Clin Psychiatry. 2000;61(Suppl 14):5–10

    ⁎

  62. Corrigan JD. Development of a scale for assessment of agitation following traumatic brain injury. J Clin Exp Neuropsychol. 1989;11:261–277
  63. Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D. The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry. 1987;143:35–39
  64. Alderman N, Knight C, Morgan C. Use of a modified version of the Overt Aggression Scale in the measurement and assessment of aggressive behaviors following brain injury. Brain Inj. 1997;11:503–523
  65. Fleminger S, Greenwood RJ, Oliver DL, et al. Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database of Systematic Reviews. 2003;(Issue 1):Art. No.: CD003299. DOI: 10.1002/14651858.CD003299
  66. Cook SP, Lawless S, Mandell GA, Reilly JS. The use of the salivagram in the evaluation of severe and chronic aspiration. Int J Pediatr Otorhinolaryngol. 1997;41:353–361
  67. Jongerius PH, van Hulst K, van den Hoogen FJ, Rotteveel JJ. The treatment of posterior drooling by botulinum toxin in a child with cerebral palsy. J Pediatr Gastroenterol Nutr. 2005;41:351–353

    ⁎

  68. Blasco PA, Allaire JH. Drooling in the developmentally disabled: Management practices and recommendations. Consortium on Drooling. Dev Med Child Neurol. 1992;34:849–862
  69. Crysdale WS. Management options for the drooling patient. Ear Nose Throat J. 1989;68:820–830
  70. Tahmassebi JF, Curzon ME. Prevalence of drooling in children with cerebral palsy attending special schools. Develop Med Child Neurol. 2003;45:613–617
  71. Jongerius PH, van Limbeek J, Rotteveel JJ. Assessment of salivary flow rate: Biologic variation and measure error. Laryngoscope. 2004;114:1801–1804
  72. Mirrett PL, Riski JE, Glascott J, Johnson V. Videofluoroscopic assessment of dysphagia in children with severe spastic cerebral palsy. Dysphagia. 1994;9:174–179
  73. Collier BD. Detection of aspiration: Scintigraphic techniques. Am J Med. 1997;103:135S–137S
  74. Akbunar AT, Kiristioglu I, Alper E, Demiray H. Diagnosis of orotracheal aspiration using radionuclide salivagram. Ann Nucl Med. 2003;17:415–416
  75. Inga CT, Reddy AK, Richardson JA, Sanders B. Application of chronic drooling in cerebral palsy patients. Am Acad Pediatr Dent. 2001;23:241–242
  76. Bachrach SJ, Walter RS, Trzcinski K. Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy. Clin Pediatr (Phil). 1998;37:485–490

    ⁎

  77. Teymoortash A, Sommer F, Mandic R, et al. Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells. Br J Pharmacol. 2007;152:161–167
  78. Suskind DL, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope. 2002;112:73–81
  79. Savarese R, Diamond M, Elovic E, Millis SR. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Am J Phys Med Rehabil. 2004;83:304–311
  80. Jongerius PH, Rotteveel JJ, van Limbeek J, Gabreels FJ, van Hulst K, van den Hoogen FJ. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology. 2004;63:1371–1375
  81. Ondo WG, Hunter C, Moore W. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease. Neurology. 2004;62:37–40
  82. Tan EK. Botulinum toxin treatment of sialorrhea: Comparing different therapeutic preparations. Eur J Neurol. 2006;13(Suppl 1):60–64
  83. Costa J, Rocha ML, Ferreira J, Evangelista T, Coelho M, de Carvalho M. Botulinum toxin type-B improves sialorrhea and quality of life in bulbar onset amyotrophic lateral sclerosis. J Neurol. 2008;255:545–550
  84. Kim H, Lee Y, Weiner D, Kaye R, Cahill AM, Yudkoff M. Botulinum toxin type A injections to salivary glands: Combination with single event multilevel chemoneurolysis in 2 children with severe spastic quadriplegic cerebral palsy. Arch Phys Med Rehabil. 2006;87:141–144
  85. Raval TH, Elliott CA. Botulinum toxin injection to the salivary glands for the treatment of sialorrhea with chronic aspiration. Ann Otol Rhinol Laryngol. 2008;117:118–122
  86. Crysdale WS, McCann C, Roske L, Joseph M, Semenuk D, Chait P. Saliva control issues in the neurologically challenged (A 30 year experience in team management). Int J Pediatr Otorhinolaryngol. 2006;70:519–527

    ⁎

  87. Tejas H, Elliott CA. Botulinum toxin injection to salivary glands for treatment of sialorrhea with chronic aspiration. Ann Otol Rhinol Laryngol. 2008;117:118–122
  88. Pena AH, Cahill AM, Gonzalez L, Baskin KM, Kim H, Towbin RB. Botulinum toxin A injection of salivary glands in children with drooling and chronic aspiration. J Vasc Interv Radiol. 2009;20:368–373
  89. Apkon S. Osteoporosis in children who have disabilities. Phys Med Rehabil Clin N Am. 2002;13:839–855
  90. Henderson RC, Kairalla J, Abbas A, Stevenson RD. Predicting low bone density in children and young adults with quadriplegic cerebral palsy. Dev Med Child Neurol. 2004;46:416–419

    ⁎

  91. Leet AI, Mesfin A, Pichard C, et al. Fractures in children with cerebral palsy. J Pediatr Orthop. 2006;26:624–627
  92. Presedo A, Dabney K, Miller F. Fractures in patients with cerebral palsy. J Pediatr Orthop. 2007;27:147–153
  93. Stevenson RD, Conaway M, Barrington JW, Cuthill SL, Worley G, Henderson RC. Fracture rate in children with cerebral palsy. Pediatr Rehab. 2006;9:396–403
  94. Henderson RC, Lin PP, Greene WB. Bone-mineral density in children and adolescents who have spastic cerebral palsy. J Bone Joint Surg. 1995;77:1671–1681
  95. King W, Levin R, Schmidt R, Oestreich A, Heubi J. Prevalence of reduced bone mass in children and adults with spastic quadriplegia. Dev Med Child Neurol. 2003;45:12–16
  96. Apkon SD, Kecskemethy HH. Bone health in children with cerebral palsy. J Ped Rehab Med. 2008;115–121

    ⁎

  97. Harcke HT, Taylor A, Bachrach S, Miller F, Henderson RC. Lateral femoral scan: An alternative method for assessing bone mineral density in children with cerebral palsy. Pediatr Padiol. 1998;28:241–246
  98. Henderson RC, Lark RK, Gurka MJ, et al. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics. 2002;110:e5

    ⁎

  99. Sullivan PB, Lambert B, Rose M, Ford-Adams M, Johnson A, Griffiths P. Prevalence and severity of feeding problems in children with neurological impairment: Oxford Feeding Study. Dev Med Child Neurol. 2000;42:674–680
  100. Hillesund E, Skranes J, Trygg KU, Bohmer T. Micronutrient status in children with cerebral palsy. Acta Paediatr. 2007;96:1195–1198
  101. Henderson RC. Vitamin D levels in noninstitutionalized children with cerebral palsy. J Child Neurol. 1997;12:443–447
  102. Matthews DJ, Wilson P. Cerebral palsy. In:  Molnar GE,  Alexander MA editor. Pediatric Rehabilitation. Philadelphia, PA: Hanley & Belfus, Inc; 1999;p. 193–218
  103. Gissel T, Poulsen CS, Vestergaard P. Adverse effects of antiepileptic drugs on bone mineral density in children. Expert Opin Drug Saf. 2007;6:267–278
  104. Caulton JM, Ward KA, Alsop CW, Dunn G, Adams JE, Mughal MZ. A randomised controlled trial of standing programme on bone mineral density in non-ambulant children with cerebral palsy. Arch Dis Child. 2004;89:131–135
  105. Chad KE, Bailey DA, McKay HA, Zello GA, Snyder RE. The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy. J Pediatr. 1999;135:115–117
  106. Henderson RC, Lark RK, Kecskemethy HH, Miller F, Harcke HT, Bachrach SJ. Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized placebo-controlled clinical trial. J Pediatr. 2002;141:6

    ⁎

  107. Dorman J. Pediatric Orthopaedics: Core Knowledge in Orthopedics. Philadelphia, PA: Elsevier Mosby; 2005;
  108. Olafsson Y, Saraste H, AlDabbagh Z. Brace treatment in neuromuscular spine deformity. J Ped Orthop. 1999;19:376–379
  109. Gupta MC, Wijesekera S, Sossan A, et al. Reliability of radiographic parameters in neuromuscular scoliosis. Spine. 2007;15:691–69532
  110. Staheli L. Practice of Pediatric Orthopedics. 2nd ed. Philadelphia, PA: Lippincott Williams Wilkins; 2006;
  111. Leopando M, Moussavi Z, Holbrow J, et al. Effect of a Soft Boston Orthosis on pulmonary mechanics in severe cerebral palsy. Pediatric Pulm. 1999;28:53–58
  112. Letts M, Rathbone D, Yamashita T, Nichol B, Keeler A. Soft Boston Orthosis in management of neuromuscular scoliosis: A preliminary report. J Pediatr Orthop. 1992;12:470–474
  113. Nash CL, Moe JH. A study of vertebral rotation. J Bone Joint Surg Am. 1969;5:223–229
  114. Cramer K, Scherl S. In: Orthopedic Surgery Essentials. Pediatrics. Philadelphia, PA: Lippincott Williams & Wilkins; 2004;p. 44–51
  115. Toree-Healy A, Samdani AF. Newer technologies for the treatment of scoliosis in the growing spine. Neruosurg Clin N Am. 2007;18:697–705
  116. Smith JT. The use of growth-sparing instrumentation in pediatric spinal deformity. Ortho Clin North Am. 2007;38:547–552
  117. Murphy N, Firth S, Jorgensen T, Young P. Spinal surgery in children with idiopathic and neuromuscular scoliosis (What's the difference?). J Ped Ortho. 2006;23:211–220
  118. Hedequist DJ. Surgical treatment of congenital scoliosis. Ortho Clin North Am. 2007;38:497–509
  119. Hell AK, Campbell RM, Hefti F. The vertical expandable prosthetic titanium rib implant for the treatment of thoracic insufficiency syndrome associated with congenital and neuromuscular scoliosis in young children. J Ped Ortho B. 2005;13:287–293
  120. Larsson E, Normelli H, Oberg B. Long-term follow-up of functioning after spinal surgery in patients with neuromuscular scoliosis. Spine. 2005;30:2145–2152

 Disclosure Key can be found on the Table of Contents and at www.pmrjournal.org

PII: S1934-1482(09)01642-6

doi: 10.1016/j.pmrj.2009.12.004

PM&R
Volume 2, Issue 3 , Pages S3-S11 , March 2010

Article Tools